👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

European shares set for second week of gains, Actelion hits record high

Published 16/12/2016, 08:29
© Reuters. Traders work at their desks in front of the German share price index DAX board in Frankfurt
ATLN
-
SASY
-
STOXX
-
SXEP
-
SX7P
-
SXDP
-

MILAN (Reuters) - European shares were set for a second straight week of gains with benchmark indexes holding near 11-month highs, with takeover expectations lifting Actelion (S:ATLN) to fresh record highs.

The pan-European STOXX 600 (STOXX) index was up 0.1 percent by 0816 GMT helped by gains among pharma (SXDP) and oil (SXEP) sector stocks.

The index has gained almost 6 percent in the past two weeks boosted by a rally in banking stocks on expectations that rising yields would ease margin pressure and a further underpinned by the strengthening of the dollar.

Actelion rose more than 8 percent, making it the biggest gainer on the STOXX. People close to the matter cited by Bloomberg said French rival Sanofi (PA:SASY) is discussing a price of about $275 per share to take over the Swiss drugmaker in a deal that could come as soon as next week.

Sanofi was down 0.8 percent.

© Reuters. Traders work at their desks in front of the German share price index DAX board in Frankfurt

Banks (SX7P) were on the back foot, down 0.3 percent, after hitting their highest since January on Thursday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.